AMENDMENT NO. 2Credit Agreement • April 29th, 2024 • QuidelOrtho Corp • In vitro & in vivo diagnostic substances • New York
Contract Type FiledApril 29th, 2024 Company Industry JurisdictionAMENDMENT NO. 2, dated as of April 25, 2024 (this “Amendment”), by and among QuidelOrtho Corporation, a Delaware corporation (the “Borrower”), the Lenders party hereto, and Bank of America, N.A., as the Administrative Agent (the “Administrative Agent”).